Quantum-Enhanced Magnetometry at Optimal Number Density.

We study the use of squeezed probe light and evasion of measurement backaction to enhance the sensitivity and measurement bandwidth of an optically pumped magnetometer (OPM) at sensitivity-optimal atom number density. By experimental observation, and in agreement with quantum noise modeling, a spin-exchange-limited OPM probed with off-resonance laser light is shown to have an optimal sensitivity determined by density-dependent quantum noise contributions. Application of squeezed probe light boosts the OPM sensitivity beyond this laser-light optimum, allowing the OPM to achieve sensitivities that it cannot reach with coherent-state probing at any density.

Laser-written vapor cells for chip-scale atomic sensing and spectroscopy.

We report the fabrication of alkali-metal vapor cells using femtosecond laser machining. This laser-written vapor-cell (LWVC) technology allows arbitrarily-shaped 3D interior volumes and has potential for integration with photonic structures and optical components. We use non-evaporable getters both to dispense rubidium and to absorb buffer gas.

Squeezed-Light Enhancement and Backaction Evasion in a High Sensitivity Optically Pumped Magnetometer.

We study the effect of optical polarization squeezing on the performance of a sensitive, quantum-noise-limited optically pumped magnetometer. We use Bell-Bloom (BB) optical pumping to excite a ^{87}Rb vapor containing 8.2×10^{12}  atoms/cm^{3} and Faraday rotation to detect spin precession.

Measurement-induced, spatially-extended entanglement in a hot, strongly-interacting atomic system.

Quantum technologies use entanglement to outperform classical technologies, and often employ strong cooling and isolation to protect entangled entities from decoherence by random interactions. Here we show that the opposite strategy-promoting random interactions-can help generate and preserve entanglement. We use optical quantum non-demolition measurement to produce entanglement in a hot alkali vapor, in a regime dominated by random spin-exchange collisions.

Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study.

Background: We investigated low-dose aspirin (ASA) efficacy and safety in subjects with silent brain infarcts (SBIs) in preventing new cerebrovascular (CVD) events as well as cognitive impairment.

Methods: We included subjects aged ≥45 years, with at least one SBI and no previous CVD. Subjects were followed up to 4 years assessing CVD and SBI incidence as primary endpoint and as secondary endpoints: (a) cardiovascular and adverse events and (b) cognitive impairment.